See more : St. James Gold Corp. (LORD.V) Income Statement Analysis – Financial Results
Complete financial analysis of All Cosmos Bio-Tech Holding Corporation (4148.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of All Cosmos Bio-Tech Holding Corporation, a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Jiangxi Haiyuan Composites Technology Co.,Ltd. (002529.SZ) Income Statement Analysis – Financial Results
- Scryb Inc. (SCYRF) Income Statement Analysis – Financial Results
- BNK Banking Corporation Limited (BBC.AX) Income Statement Analysis – Financial Results
- China BlueChemical Ltd. (3983.HK) Income Statement Analysis – Financial Results
- ProVen VCT plc (PVN.L) Income Statement Analysis – Financial Results
All Cosmos Bio-Tech Holding Corporation (4148.TW)
About All Cosmos Bio-Tech Holding Corporation
All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In addition, the company is involved in the research and forest plantation activities. It also exports its products to Taiwan, Indonesia, Vietnam, and China. All Cosmos Bio-Tech Holding Corporation was founded in 1999 and is headquartered in George Town, the Cayman Islands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.83B | 3.70B | 2.20B | 1.64B | 1.77B | 2.69B | 2.26B | 2.07B | 2.26B | 2.23B | 1.87B | 1.80B | 1.40B |
| Cost of Revenue | 2.24B | 2.56B | 1.60B | 1.27B | 1.37B | 1.91B | 1.51B | 1.41B | 1.63B | 1.66B | 1.44B | 1.31B | 1.00B |
| Gross Profit | 587.98M | 1.14B | 594.37M | 372.15M | 393.31M | 774.59M | 751.52M | 655.42M | 622.89M | 568.35M | 439.79M | 491.58M | 401.70M |
| Gross Profit Ratio | 20.80% | 30.73% | 27.05% | 22.65% | 22.25% | 28.82% | 33.20% | 31.73% | 27.59% | 25.47% | 23.46% | 27.24% | 28.60% |
| Research & Development | 3.73M | 2.28M | 3.85M | 2.54M | 4.66M | 6.59M | 4.46M | 5.86M | 6.09M | 7.91M | 17.98M | 13.64M | 13.04M |
| General & Administrative | 236.17M | 229.12M | 178.22M | 153.01M | 157.92M | 187.30M | 184.35M | 169.65M | 178.94M | 196.29M | 155.00M | 127.86M | 95.29M |
| Selling & Marketing | 160.19M | 246.45M | 199.56M | 121.51M | 110.34M | 197.89M | 155.99M | 155.32M | 153.95M | 187.37M | 127.20M | 148.07M | 0.00 |
| SG&A | 396.35M | 475.57M | 377.78M | 274.52M | 268.26M | 385.19M | 340.34M | 324.97M | 332.89M | 383.66M | 282.20M | 275.93M | 95.29M |
| Other Expenses | 0.00 | -27.65M | 41.76M | 33.90M | 40.19M | 60.93M | 13.73M | 30.27M | 0.00 | 0.00 | 0.00 | 1.15M | 122.43M |
| Operating Expenses | 375.99M | 477.85M | 381.63M | 277.06M | 272.92M | 391.78M | 344.80M | 330.82M | 338.98M | 391.57M | 300.18M | 289.56M | 230.76M |
| Cost & Expenses | 2.64B | 3.04B | 1.98B | 1.55B | 1.65B | 2.30B | 1.86B | 1.74B | 1.97B | 2.05B | 1.74B | 1.60B | 1.23B |
| Interest Income | 30.42M | 11.49M | 9.43M | 18.80M | 17.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.58M | 4.95M |
| Interest Expense | 3.98M | 18.81M | 4.54M | 4.44M | 9.45M | 18.67M | 13.52M | 24.31M | 25.57M | 22.92M | 18.89M | 9.28M | 8.64M |
| Depreciation & Amortization | 49.15M | 49.01M | 48.59M | 50.16M | 53.25M | 46.22M | 40.84M | 53.89M | 47.74M | 49.72M | 43.17M | 29.80M | 24.80M |
| EBITDA | 305.42M | 699.84M | 373.03M | 205.56M | 166.67M | 463.92M | 461.29M | 408.75M | 296.52M | 255.03M | 199.58M | 247.35M | 193.03M |
| EBITDA Ratio | 10.81% | 18.76% | 14.30% | 11.97% | 12.09% | 18.23% | 20.38% | 19.79% | 14.69% | 10.15% | 9.75% | 13.68% | 21.05% |
| Operating Income | 189.90M | 645.50M | 265.62M | 146.48M | 160.43M | 443.73M | 420.45M | 354.87M | 283.91M | 176.78M | 139.61M | 217.13M | 270.87M |
| Operating Income Ratio | 6.72% | 17.43% | 12.09% | 8.92% | 9.08% | 16.51% | 18.57% | 17.18% | 12.58% | 7.92% | 7.45% | 12.03% | 19.29% |
| Total Other Income/Expenses | 67.74M | -11.55M | 48.34M | 3.19M | -16.58M | -44.71M | -13.52M | -24.31M | -60.69M | 5.61M | -2.09M | 6.25M | -12.87M |
| Income Before Tax | 257.63M | 633.95M | 321.59M | 149.67M | 103.82M | 399.02M | 406.94M | 330.55M | 223.22M | 182.39M | 137.52M | 208.27M | 159.58M |
| Income Before Tax Ratio | 9.11% | 17.12% | 14.64% | 9.11% | 5.87% | 14.85% | 17.98% | 16.00% | 9.89% | 8.17% | 7.33% | 11.54% | 11.36% |
| Income Tax Expense | 68.32M | 177.93M | 84.93M | 51.50M | 65.14M | 50.33M | 10.51M | 38.29M | 7.07M | 7.18M | 2.74M | 494.00K | -1.93M |
| Net Income | 139.36M | 368.20M | 198.13M | 82.20M | 35.69M | 305.06M | 322.87M | 243.22M | 197.06M | 195.64M | 158.48M | 210.36M | 162.32M |
| Net Income Ratio | 4.93% | 9.95% | 9.02% | 5.00% | 2.02% | 11.35% | 14.26% | 11.77% | 8.73% | 8.77% | 8.45% | 11.66% | 11.56% |
| EPS | 2.18 | 5.75 | 3.09 | 1.28 | 0.56 | 4.76 | 5.31 | 4.30 | 3.52 | 3.78 | 3.17 | 4.21 | 3.25 |
| EPS Diluted | 1.97 | 5.65 | 3.09 | 1.28 | 0.56 | 4.75 | 5.30 | 4.25 | 3.48 | 3.76 | 3.17 | 4.21 | 3.25 |
| Weighted Avg Shares Out | 64.03M | 64.03M | 64.03M | 64.03M | 64.03M | 64.03M | 60.79M | 56.50M | 56.01M | 51.76M | 49.99M | 49.97M | 49.94M |
| Weighted Avg Shares Out (Dil) | 70.77M | 66.04M | 64.21M | 64.12M | 64.10M | 64.24M | 60.95M | 57.23M | 56.61M | 52.03M | 49.99M | 49.97M | 49.94M |
Source: https://incomestatements.info
Category: Stock Reports